Mettler-Toledo International (NYSE:MTD) Stock Acquired Rep. Robert Bresnahan, Jr.

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Mettler-Toledo International Inc. NYSE: MTD. In a filing disclosed on May 31st, the Representative disclosed that they had bought between $1,001 and $15,000 in Mettler-Toledo International stock on May 15th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Zimmer Biomet NYSE: ZBH on 5/15/2025.
• Sold $15,001 - $50,000 in shares of Elevance Health NYSE: ELV on 5/15/2025.
• Sold $15,001 - $50,000 in shares of PepsiCo NASDAQ: PEP on 5/15/2025.
• Sold $1,001 - $15,000 in shares of WEC Energy Group NYSE: WEC on 5/15/2025.
• Purchased $15,001 - $50,000 in shares of Advanced Micro Devices NASDAQ: AMD on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of Hershey NYSE: HSY on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of Kraft Heinz NASDAQ: KHC on 5/15/2025.
• Sold $1,001 - $15,000 in shares of Exxon Mobil NYSE: XOM on 5/15/2025.
• Sold $1,001 - $15,000 in shares of Danaher NYSE: DHR on 5/15/2025.
• Sold $1,001 - $15,000 in shares of International Flavors & Fragrances NYSE: IFF on 5/15/2025.

Mettler-Toledo International Trading Up 1.7%

NYSE MTD traded up $19.27 on Friday, reaching $1,183.88. The stock had a trading volume of 158,407 shares, compared to its average volume of 151,346. The business has a 50 day moving average price of $1,091.77 and a 200 day moving average price of $1,204.66. Mettler-Toledo International Inc. has a 1 year low of $946.69 and a 1 year high of $1,546.93. The company has a market capitalization of $24.60 billion, a price-to-earnings ratio of 29.21, a P/E/G ratio of 3.30 and a beta of 1.38.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The firm had revenue of $883.74 million for the quarter, compared to the consensus estimate of $876.61 million. During the same quarter in the previous year, the company posted $8.89 earnings per share. The business's quarterly revenue was down 4.6% compared to the same quarter last year. On average, analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Mettler-Toledo International

Several large investors have recently added to or reduced their stakes in MTD. Vanguard Group Inc. raised its holdings in shares of Mettler-Toledo International by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock worth $3,003,485,000 after buying an additional 30,535 shares in the last quarter. Alliancebernstein L.P. raised its holdings in shares of Mettler-Toledo International by 21.6% in the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after buying an additional 126,147 shares in the last quarter. Geode Capital Management LLC increased its holdings in Mettler-Toledo International by 2.0% during the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after purchasing an additional 11,032 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Mettler-Toledo International by 5.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock valued at $568,032,000 after purchasing an additional 25,272 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. increased its holdings in Mettler-Toledo International by 11.9% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock valued at $479,673,000 after purchasing an additional 43,082 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have commented on MTD. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research note on Monday, April 7th. Robert W. Baird decreased their price target on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Wells Fargo & Company upped their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their price target for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their price target for the stock from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, Mettler-Toledo International currently has an average rating of "Hold" and an average target price of $1,302.11.

Insider Activity at Mettler-Toledo International

In related news, Director Michael A. Kelly sold 1,062 shares of the firm's stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director now directly owns 120 shares of the company's stock, valued at $139,191.60. This trade represents a 89.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.94% of the company's stock.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.